UAE Dermatology Treatment Drugs Market Analysis

$3,000.00 – $7,500.00

  • Type: Therapeutics Area
  • Published : February 2022
  • Region: UAE
  • Country: Other

  • Report ID : 5105

  • Format: PPT, PDF

UAE Dermatology Treatment Drugs Market Analysis: Segmented by Drug Class, Drug Type, Prescription Mode, Application, Route of Administration, End-User, Distribution Channel – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5105 Categories: ,

Report Description of the UAE Dermatology Treatment Drugs Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for UAE Dermatology Treatment Drugs Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the UAE Dermatology Treatment Drugs Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

UAE Dermatology Treatment Drugs Market Analysis Executive Summary

Dermatology is a medical field that deals with the diagnosis, prevention, and treatment of various skin, nail, and hair-related diseases such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also referred to as dermatologic, are products that are applied topically to the skin.

Market Size and Key Findings

The UAE Dermatology Treatment Drugs Market Analysis size stood at around USD xx% billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 7% during the forecast period.

Middle East Dermatology Drugs Market is expected to grow by 2028, at a CAGR of 7% between 2021 and 2028.

Market Dynamics

Market Growth Drivers Analysis

The rising number of patients suffering from skin infections or disorders, such as scars, acne, dermatitis, etc., is likely to spur the growth opportunities for the market in the forecast period. The increasing awareness regarding numerous dermatology products curing skin problems and the surging product portfolios contributes to the market growth.

Market Restraints

High dependency on imports and frequent drug recalls by the Ministry of Health Saudi Arabia is the biggest challenge that could restrain the market growth.

Covid-19 Market Impact Analysis

Due to the outbreak of the COVID-19 pandemic, the Middle East dermatology drug market came to a standstill position due to the temporary closure of dermatology-clinics during the lockdown. However, the market can regain its pace in the forecast period due to lockdown relaxations by the government.

Competitive Landscape

Key Players

The major players covered in the report are Novartis AG, Pfizer Inc., Eli Lilly and Company., Johnson & Johnson Services, Inc., Almirall, S.A, Mylan N.V., Sun Pharmaceutical Industries Ltd., UCB S.A., Belgium, Glenmark Pharmaceuticals Limited, Tolmar Pharmaceuticals, Inc., GlaxoSmithKline plc., Galderma Laboratories, L.P., Teva Pharmaceutical Industries Ltd., LEO Pharma A/S, MELINTA THERAPEUTICS, INC. – THE ANTIBIOTICS COMPANY, Mayne Pharma Group Limited, BIOFRONTERA AG, AbbVie Inc. among others.

Products in Pipeline

  • Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions. Their pipeline refers to drugs in development, including those in preclinical testing, clinical development, regulatory approval and lifecycle management.

Notable Recent Deals

  • 75-year-old British expat undergoes successful cornea transplant surgery in the UAE
  • KBBO Group becomes the majority shareholder of a one of a kind Population Health Management Delivery System company, Mobile Doctors 24-7
  • In November 2018, KBBO Group and Guggenheim Partners Announce JV

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The Emirates Dermatology Society is proud to announce the 4th yearly EDS Conference. This premier conference is scheduled has been held on 25 – 27 November 2021, InterContinental Dubai – Festival City, in Dubai – United Arab Emirates. The aim of Emirates Dermatology Society Conference 2021 is to provide a forum of the highest standard for scientific (clinical & experimental), educational and social exchange between professionals involved in Dermatology care (adult & paediatrics) in order to achieve progress in the clinical care of patients. It also aims to build bridges between dermatologists practicing all over the world to easily exchange knowledge and experience.

The Emirates Dermatology Society is a non-profit medical society founded in 2002 under the supervision of the Emirates Medical Association comprising of Dermatologists, Aestheticians, and Skin Specialists who are committed in keeping up with the dynamic trends in the field of Dermatology.

The Emirates Dermatology Society regularly holds workshops, conferences, and exhibitions in partnership with various organizations such as the International Peelings Society, Oman Dermatology Society, International Master Course on Aging Science, Swiss Academy of Cosmetic Dermatology and Aesthetic Medicine, and Saudi Society of Dermatology. The main goal of the society is to discover new and effective methods in the improvement of medical conditions of patients.

  • The Emirates Dermatology Society plays a key role in the continuous improvement in the quality of dermatology services in the UAE and the wider region.
  • The Emirates Dermatology Society has an active management committee that oversees the day to day running of the organization.
  • It brings together the dermatologist in the UAE so they can share their experiences and knowledge with their colleagues

1. Report Description of the UAE Dermatology Treatment Drugs Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. UAE Dermatology Treatment Drugs Market Analysis Executive Summary
2.1 UAE Dermatology Treatment Drugs Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of UAE Dermatology Treatment Drugs Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Surging Patient Population to Support Market Growth
3.1.2 The increasing awareness regarding numerous dermatology products
3.2 Market Restraints Analysis
3.2.1 Product recall of products having these drugs
3.2.2 High dependency on imports
3.3 Covid-19 Market Impact Analysis
4. UAE Dermatology Treatment Drugs Market Segmentation
4.1 By Drug Class:
4.1.1 Corticosteroids
4.1.2 Retinoids
4.1.3 Monoclonal Antibodies
4.1.4 Antibiotics Agent
4.1.5 Antiviral Agents
4.1.6 Antifungal Drugs
4.1.7 Antihistamines Agents
4.1.8 Immunosuppressive Drugs
4.2 By Drug Type:
4.2.1 Branded
4.2.2 Generics
4.3 By Prescription Mode:
4.3.1 Prescription based drugs
4.3.2 Over-the-counter drugs
4.4 By Application:
4.4.1 Psoriasis
4.4.2 Atopic dermatitis
4.4.3 Acne & Scar
4.4.4 Skin Cancer
4.4.5 Rosacea
4.5 By Route of Administration:
4.5.1 Topical
4.5.2 Oral
4.5.3 Parenteral Administration
4.6 By End-User:
4.6.1 Homecare
4.6.2 Hospitals & Cosmetics clinics
4.6.3 Dermatology Clinics
4.7 By Distribution Channel:
4.7.1 Direct
4.7.2 Retail/wholesale
4.7.3 Online
5. UAE Dermatology Treatment Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives Dermatology Drug Market
6.4 Notable recent deals in Dermatology Drug Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Bausch Health Companies Inc. overview
Product & Services, Strategies & Financials
7.2 Johnson & Johnson Services, Inc. Company overview
Product & Services, Strategies & Financials
7.3 GlaxoSmithKline Plc. Company overview
Product & Services, Strategies & Financials
7.4 Eli Lilly and Company overview
Product &, Strategies & Financials
7.5 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.6 Novartis AG Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Dermatology Drug market
9.2 Future Opportunities
10. Strategic Recommendations

UAE Dermatology Treatment Drugs Market Analysis Segmentation

By Drug Class:

On the basis of drug class, the market is segmented into corticosteroids, retinoids, monoclonal antibodies, antibiotics agents, antiviral agents, antifungal drugs, antihistamines agents, immunosuppressive drugs and others.

By Drug Type:

Based on drug type, the market classifies into branded drugs and generic drugs. Among these segments, generic drugs held the largest share in the Middle East Dermatology Drug Market in 2019. The primary factor driving the growth of these drugs is the burgeoning trend of outsourcing as a market strategy by vendors to reduce their capital. Moreover, the cost-effectiveness of generic drugs provides them with a competitive benefit over branded drugs.

By Prescription Mode:

On the basis of prescription mode, the market is segmented into prescription based drugs and over-the-counter drugs. In 2020, prescription based drugs segment dominates the Middle East dermatology drugs market, because maximum branded drugs sold via prescription based drugs mode over others in Middle East Asia.

By Application

Based on application, the atopic dermatitis segment acquired the largest market share in Middle East Dermatology Drug Market in 2019. Atopic dermatitis is one of the most common kinds of eczema in which skin gets red and itchy. The growth of this segment attributes to the rising expenditure on R&D activities and campaigns to raise atopic dermatitis awareness, thereby resulting in the rise of the dermatology drug market.

By Route of Administration:

On the basis of route of administration, the market is segmented into oral, topical and parenteral. In 2020, topical segment dominates the UAE dermatology drugs market; due to majority of dermatology drugs are available in cream, gels, ointment and others.

By End-User:

On the basis of end user, the market is segmented into homecare, hospitals, dermatology clinics and others. Homecare segment dominate the UAE dermatology drugs market due to high volume demand from this end use. Majority of acne and psoriasis drugs were sold in the market by this end use.

By Distribution Channel:

On the basis of distribution channel, the market is segmented into retail pharmacy, hospitals pharmacy, online pharmacy and others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    Inquiry before buying


      Inquiry Form

      Fill below details and we will get back to you.

      Payment options

      Why us?

      • 150+ Analyst and Consultants

        Our team of 150+ analyst and consultants carry a rich experience working in Life sciences domain

      • 13000+ reports

        Insights10 has 13000+ ready available syndicated market research reports

      • Specialised in Lifesciences Market

        One stop solutions for all your Life-sciences market research requirements

      This report addresses

      • Market intelligence to enable effective decision making
      • Growth opportunities and trend analysis
      • Competitive benchmarking
      • Historical data & forecasts
      • Regional opportunities

      Need more?

      • Speak to our analyst to know how this research was put together
      • Add more countries or regions as part of customisation
      • Understand how this report can have direct impact on your revenue

      Related products

      Get a custom report based on your requirements